ARCHIVES

NCAB Review Of Cancer Control Program Finds It Has Made Substantial Progress But Has Problems

This article is from The Cancer Letter archive.

Vol. 04 No. 41 | October 13, 1978

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

December 27, 2013

Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients

November 29, 2002

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

September 28, 2001

Circulating Tumor Cells Predict Treatment Resistance In Study Of Metastatic Breast Cancer

August 30, 2013

Hrushesky To Pursue Chronobiology Work At Albany, Forms Group

April 28, 1989

In Brief: Simone Named New Director At St. Jude; Schein To Leave Georgetown For Job At Smith-Kline

September 16, 1983